#United States #Chicago #diabetes #Real-World Data #T1D Exchange

T1D Exchange's Insights at the ADA 85th Scientific Sessions

The T1D Exchange, a nonprofit dedicated to enhancing research and care for diabetes, is gearing up to showcase its latest findings during the American Diabetes Association (ADA) 85th Scientific Sessions in Chicago. From June 20-23, 2025, over a dozen presentations will explore important trends in diabetes management, centered on real-world data gathered from over 20,000 individuals with type 1 and type 2 diabetes.

Highlights of the Presentations

One of the key focuses of this year's presentations is the increased adoption of Continuous Glucose Monitoring (CGM) technology among people living with type 2 diabetes (T2D). Furthermore, studies will delve into the growing utilization of glucagon-like peptide-1 (GLP-1) therapies, which have been linked to significant improvements in diabetes management and overall patient care.

David Walton, CEO of T1D Exchange, emphasized the importance of collaborative research, stating, “By uniting over 60 endocrinology clinics and drawing on data from 150,000+ individuals, we are creating a robust evidence base that ultimately aims to improve diabetes care.” The findings from this research not only aim to address clinical outcomes but also the emotional and financial burdens faced by those affected by diabetes.

Engaged Community Impact

Wendy Wolf, PhD, Vice President of Registry and Outcomes Research at T1D Exchange, noted that many presentations reflect the invaluable insights gained from patient participation in the Registry. This involvement has allowed the organization to understand the multifaceted challenges faced by those living with diabetes. The build-up has been significant, with thousands of participants contributing valuable data regarding their experiences, which ultimately emphasizes the real-world impacts of living with diabetes.

The Role of the T1D Exchange Registry

The T1D Exchange Registry is an online longitudinal study that seeks to capture comprehensive data on individuals with type 1 diabetes and their caregivers. Its design aims to lower the barriers of participation in diabetes research, specifically among populations that have often been underrepresented in clinical trials. This has proven crucial in facilitating targeted research initiatives and enabling participants to engage with various medical trials.

Since 2020, T1D Exchange has published over 100 research studies that impact diabetes care and management. By leveraging patient-reported data alongside clinical findings, the organization is working towards refining clinical practices based on the real experiences of individuals living with diabetes.

Looking Ahead

The ADA 85th Scientific Sessions present a vital opportunity for T1D Exchange to communicate its findings and collaborate with healthcare professionals dedicated to diabetes improvement. With presentations scheduled over several days, attendees will have a chance to explore a variety of topics that underscore the importance of technology in diabetes management, the psychological dimensions of chronic illness, and equitable healthcare access.

In conclusion, T1D Exchange is at the forefront of diabetes research, utilizing real-world evidence to drive impactful changes in care protocols and ultimately improve the lives of individuals affected by diabetes.

To learn more about T1DX-QI member clinics or the T1D Exchange Registry, visit their respective websites for additional information.